“…1,3,4-Oxadiazole heterocyclic core is a versatile lead molecule for designing several potential bioactive agents. 1,3,4-Oxadiazole derivatives are reactive pharmacophores and exhibit a wide range of biological activities including antibacterial [3,4,7], antitubercular [10], antifungal [13,18], antiviral [8], cytotoxic [15], anticancer [9,17], anti-inflammatory and analgesic [2,11,22] activities. A variety of therapeutically active agents such as raltegravir (antiretroviral drug), zibotentan (anticancer agent), furamizole (nitrofuran antibacterial agents), tiodazosin and nesapidil (antihypertensive agents) are based on 1,3,4-oxadiazole moiety [23].…”